AREA OF EXPERTISE
Generics, Biosimilars, and Value-Added Medicines
YEARS OF INDUSTRY EXPERIENCE
Generics Bulletin's Executive Editor Dave Wallace has more than a decade of experience reporting on the global generics, biosimilars and value-added medicines industries. Bringing his education in law to bear on legislative and regulatory affairs, he also keeps a close eye on corporate strategy, personnel moves, and product pipelines.
Generics Bulletin's annual Top 50 feature compiles a ranking of the off-patent industry's leading players. Ordering companies by size based on their generics, biosimilars and APIs business, the Generics Bulletin Top 50 provides a comprehensive rundown of the industry's most significant firms, offers insights into how their recent experiences have affected their standing among their peers and reveals how industry trends have shaped the competitive landscape over the past year.
Get unrivalled coverage, news, and analysis of the global generics, biosimilars, and value-added edicines industries from the industry experts at Generics Bulletin..
Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments.
Register for your free trial today to find out what our editors and journalists are reporting on now.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: